Darwin Global Management, Ltd.

Q4 2023 13F-HR Holdings

Location
St. Helier, Y9
Holdings as of
12/31/2023
Date filed
2/14/2024
Form type
13F-HR
Num holdings
8
Total value ($000)
$509,484
Net value change ($000)
+225,332 (79.3%)
New positions
8
Sold out positions
3
Turnover %
155.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/14/2023 Next filing: 5/15/2024 SEC filing

Snapshot: Change Analysis

Compared to Q3 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ambrx Biopharma, Inc. 237,646 NEW
TGTX 69,116 NEW
MLTX 62,763 NEW
CYTK 50,094 NEW
KROS 42,163 NEW
PCVX 36,421 NEW
SpringWorks Therapeutics, Inc. 7,035 NEW
NUVL 4,246 NEW
Top Reduces (Value $000, Stocks/ETFs)
Ambrx Biopharma Cayman, Inc. -191,919 -100.0%
IMVT -69,807 -100.0%
ARGX -22,426 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type